<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00940888</url>
  </required_header>
  <id_info>
    <org_study_id>60020938</org_study_id>
    <nct_id>NCT00940888</nct_id>
  </id_info>
  <brief_title>SJ4 Post Approval Study in Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Defibrillator Patients</brief_title>
  <official_title>SJ4 Post Approval Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Jude Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. Jude Medical</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to characterize the chronic performance of the St. Jude Medical
      SJ4 connector and RV high voltage SJ4 leads.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2009</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">September 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Right Ventricle (RV) Bipolar Capture Thresholds</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Complication Free Survival Rate Related to the High Voltage RV SJ4 Lead or SJ4 Connector</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">1701</enrollment>
  <condition>Tachyarrhythmias</condition>
  <condition>Sudden Cardiac Death</condition>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>No treatment: ICD/CRTD-indicated</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SJ4 connector and RV high voltage SJ4 lead</intervention_name>
    <description>Standard of care implantation of SJ4 device system</description>
    <arm_group_label>No treatment: ICD/CRTD-indicated</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        ICD and CRTD indicated patients
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Have an approved indication per ACC/AHA/HRS guidelines for implantation of heart
             failure or life-threatening ventricular tachyarrhythmias and will be implanted with a
             St. Jude Medical SJ4 system.

          -  Have the ability to provide informed consent for study participating and be willing
             and able to comply with the prescribed follow-up test and schedule of evaluations.

        Exclusion Criteria:

          -  Be currently participating in a clinical investigation that includes an active
             treatment arm.

          -  Have a life expectancy of less than 6 months due to any condition.

          -  Be less than 18 years of age.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bruce Wilkoff, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Clevleland Clinic Foundation</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Cleveland Clinic Foundation</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 14, 2009</study_first_submitted>
  <study_first_submitted_qc>July 15, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 16, 2009</study_first_posted>
  <results_first_submitted>January 12, 2017</results_first_submitted>
  <results_first_submitted_qc>May 2, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">August 14, 2017</results_first_posted>
  <last_update_submitted>October 30, 2017</last_update_submitted>
  <last_update_submitted_qc>October 30, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 5, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ICD</keyword>
  <keyword>CRTD</keyword>
  <keyword>Heart Failure</keyword>
  <keyword>DF4</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Death</mesh_term>
    <mesh_term>Death, Sudden, Cardiac</mesh_term>
    <mesh_term>Tachycardia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>SJ4 System Implanted</title>
          <description>SJ4 connector and RV high voltage SJ4 lead (SJ4 system) were implanted in subjects who received a standard of care ICD or CRT-D system for the treatment of heart failure or life-threatening ventricular tachyarrhythmia(s).</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="1701">Total number of subjects consented</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="866">Subjects that completed the 60 month follow up visit</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="835"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Unsuccessful Implant</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="461"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawn - Non-Death</title>
              <participants_list>
                <participants group_id="P1" count="364"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Participants had an approved indication, as per ACC/AHA/HRS guidelines, for implantation of an ICD or CRT-D system for treatment of heart failure or life-threatening ventricular tachyarrhythmia(s) and will be implanted with a St. Jude Medical SJ4 system and had given informed consent prior to enrollment.</population>
      <group_list>
        <group group_id="B1">
          <title>SJ4 System Implanted</title>
          <description>SJ4 connector and RV high voltage SJ4 lead (SJ4 system) were implanted in subjects who received a standard of care ICD or CRT-D system for the treatment of heart failure or life-threatening ventricular tachyarrhythmia(s).</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="1701"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="65" spread="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="482"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1219"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>American Indian Or Alaska Native</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black or African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="235"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hispanic or Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Iranian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Middle Eastern</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Native Hawaiian or Pacific Islander</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other- Non Hispanic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Persian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1382"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hispanic/ Black (Puerto Rican)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1701"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>New York Heart Association (NYHA) Class</title>
          <description>NHYA classification:Class I-no limitation of physical activity, ordinary physical activity doesn't cause undue breathlessness, fatigue, or palpitations, Class II-slight limitation of physical activity;comfortable at rest; ordinary physical activity results in fatigue, palpitation, dyspnea, Class III-marked limitation of physical activity;comfortable at rest;less than ordinary activity causes fatigue, palpitation, or dyspnea, class IV-Unable to carry on any physical activity without discomfort; symptoms at rest can be present; if any physical activity is undertaken, discomfort is increased.</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Class 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Class 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="541"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Class 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="816"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Class 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Not Available</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="221"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Left Ventricular (LV) Ejection Fraction (%)</title>
          <units>Percentage</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="29" spread="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Primary Indication for Device Implant</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>CRT-D Upgrade</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DEFINITE</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Familial Condition</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HF With Wide QRS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="484"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HF Without QRS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HF Without Sinus Rhythm</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ICD Upgrade</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>MADIT II</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="228"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PAVE</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Physician Designated</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SCD-HeFT</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="409"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Syncope</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>VF</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>VT</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="164"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Not Available</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Right Ventricle (RV) Bipolar Capture Thresholds</title>
        <time_frame>5 years</time_frame>
        <population>Study participants with RV bipolar capture threshold at the 5 year follow up visit.</population>
        <group_list>
          <group group_id="O1">
            <title>SJ4 System Implanted</title>
            <description>SJ4 connector and RV high voltage SJ4 lead (SJ4 system) were implanted in subjects who received a standard of care ICD or CRT-D system for the treatment of heart failure or life-threatening ventricular tachyarrhythmia(s).</description>
          </group>
        </group_list>
        <measure>
          <title>Right Ventricle (RV) Bipolar Capture Thresholds</title>
          <population>Study participants with RV bipolar capture threshold at the 5 year follow up visit.</population>
          <units>Volts</units>
          <param>Mean</param>
          <dispersion>90% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="856"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.92" lower_limit="0.89" upper_limit="0.95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Complication Free Survival Rate Related to the High Voltage RV SJ4 Lead or SJ4 Connector</title>
        <time_frame>5 years</time_frame>
        <group_list>
          <group group_id="O1">
            <title>SJ4 System Implanted</title>
            <description>SJ4 connector and RV high voltage SJ4 lead (SJ4 system) were implanted in subjects who received a standard of care ICD or CRT-D system for the treatment of heart failure or life-threatening ventricular tachyarrhythmia(s).</description>
          </group>
        </group_list>
        <measure>
          <title>Complication Free Survival Rate Related to the High Voltage RV SJ4 Lead or SJ4 Connector</title>
          <units>percentage of patients</units>
          <param>Number</param>
          <dispersion>90% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1701"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="96.4" lower_limit="95.5" upper_limit="97.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>SJ4 System Implanted</title>
          <description>SJ4 connector and RV high voltage SJ4 lead (SJ4 system) were implanted in subjects who received a standard of care ICD or CRT-D system for the treatment of heart failure or life-threatening ventricular tachyarrhythmia(s).</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1701"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>1</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="376" subjects_at_risk="1701"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>RV Lead or DF4 Connector Related Complication</sub_title>
                <description>RV lead or DF4 connector related complications (an adverse event caused by or associated with the study device, system component(s), and or procedure that requires invasive intervention)</description>
                <counts group_id="E1" events="54" subjects_affected="50" subjects_at_risk="1701"/>
              </event>
              <event>
                <sub_title>System and/or Procedure Related Complication</sub_title>
                <description>Various complications (an adverse event caused by or associated with the study device, system component(s), and or procedure that requires invasive intervention) reported that did not meet the &lt;1% report threshold.</description>
                <counts group_id="E1" events="64" subjects_affected="44" subjects_at_risk="1701"/>
              </event>
              <event>
                <sub_title>LV Lead Dislodgment or Migration Complication</sub_title>
                <description>LV Lead dislodgement and migration complication (an adverse event caused by or associated with the study device, system component(s), and or procedure that requires invasive intervention).</description>
                <counts group_id="E1" events="24" subjects_affected="21" subjects_at_risk="1701"/>
              </event>
              <event>
                <sub_title>RA Lead Dislodgement or Migration Complication</sub_title>
                <description>RA lead dislodgement complication (an adverse event caused by or associated with the study device, system component(s), and or procedure that requires invasive intervention).</description>
                <counts group_id="E1" events="25" subjects_affected="21" subjects_at_risk="1701"/>
              </event>
              <event>
                <sub_title>System and/or Procedure Related Observation</sub_title>
                <description>Observations (an adverse event caused by or associated with the study device, system component(s), and or procedure that does not require invasive intervention) that did not meet the &lt;1% reporting threshold.</description>
                <counts group_id="E1" events="94" subjects_affected="38" subjects_at_risk="1701"/>
              </event>
              <event>
                <sub_title>RV Lead or DF4 Connector Related Observation</sub_title>
                <description>Summary of RV Lead or DF4 Connector Related Observations (an adverse event caused by or associated with the study device, system component(s), and or procedure that does not require invasive intervention).</description>
                <counts group_id="E1" events="52" subjects_affected="45" subjects_at_risk="1701"/>
              </event>
              <event>
                <sub_title>Elevated LV Pacing Thresholds Observation</sub_title>
                <description>Elevated LV pacing threshold observations ((an adverse event caused by or associated with the study device, system component(s), and or procedure that does not require invasive intervention).</description>
                <counts group_id="E1" events="24" subjects_affected="21" subjects_at_risk="1701"/>
              </event>
              <event>
                <sub_title>Inappropriate Shock(s) Observation</sub_title>
                <description>Therapy delivered for non-ventricular arrhythmias falling within the VT zones programmed in the device reported observations.</description>
                <counts group_id="E1" events="36" subjects_affected="33" subjects_at_risk="1701"/>
              </event>
              <event>
                <sub_title>LV Phrenic Nerve/ Diaphragmatic Stimulation Observation</sub_title>
                <description>LV Phrenic nerve/ diaphragmatic stimulation observation(an adverse event caused by or associated with the study device, system component(s), and or procedure that does not require invasive intervention).</description>
                <counts group_id="E1" events="56" subjects_affected="51" subjects_at_risk="1701"/>
              </event>
              <event>
                <sub_title>RA Oversensing Observation</sub_title>
                <description>RA over sensing observations (an adverse event caused by or associated with the study device, system component(s), and or procedure that does not require invasive intervention).</description>
                <counts group_id="E1" events="47" subjects_affected="40" subjects_at_risk="1701"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Infection Complication</sub_title>
                <description>Infection complications (an adverse event caused by or associated with the study device, system component(s), and or procedure that requires invasive intervention) reported.</description>
                <counts group_id="E1" events="37" subjects_affected="36" subjects_at_risk="1701"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Lead Dislodgement or Migration &lt;30 days after Implant Complication</sub_title>
                <description>All were resolved with lead repositioning or replacement.</description>
                <counts group_id="E1" events="22" subjects_affected="21" subjects_at_risk="1701"/>
              </event>
              <event>
                <sub_title>Bleeding/ Hematoma Observation</sub_title>
                <description>Oozing/bleeding at site of incision following implant/system revision of implanted device system observation.</description>
                <counts group_id="E1" events="38" subjects_affected="38" subjects_at_risk="1701"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Grant Kim, Director Clinical Studies</name_or_title>
      <organization>Saint Jude Medical</organization>
      <phone>818-493-3147</phone>
      <email>gkim@sjm.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

